Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 13, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to reporting specific shareholding transactions and does not contain consolidated financial statements or operational metrics.
Material Changes
The material changes reported are specific to the equity holdings of three directors under various performance and incentive plans. These changes resulted from the notional re-investment of dividends paid to shareholders on April 7, 2005:
- Dr. J.P. Garnier: Notional increase of 3,819.757 ADRs at $47.43 per ADR (Performance Share Plan); increase of 345.940 ADRs at $45.980 per ADR (Performance Share Plan); increase of 1,589.063 ADRs at $45.980 per ADR (SmithKline Beecham Mid-Term Incentive Plan).
- Dr. T. Yamada: Notional increase of 1,145.928 ADRs at $47.43 per ADR (Performance Share Plan).
- Mr. J.S. Heslop: Notional increase of 148.919 Ordinary Shares at £12.49 per share (Performance Share Plan).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document focuses solely on the administrative reporting of director share plan adjustments.
Investor Verification Points
- Verify the total aggregate increase in ADRs and Ordinary Shares held by Dr. J.P. Garnier across the three distinct plans mentioned.
- Confirm the dividend payment date of April 7, 2005, and the corresponding share prices ($47.43, $45.980, and £12.49) used for the re-investment calculations.
- Note that the accrued notional dividends are contingent upon the vesting of holdings at the end of the relevant three-year measurement period.